PubMedCrossRef 25 Jouini A, Ben Slama K, Vinué L, Ruiz E, Saenz

PubMedCrossRef 25. Jouini A, Ben Slama K, Vinué L, Ruiz E, Saenz Y, Somalo S, Klibi N, Zarazaga M, Ben Moussa M, Boudabous A, Torres C: Detection of unrelated Escherichia coli strains harboring genes of CTX-M-15, OXA-1, and AAC(6′)-Ib-cr enzymes in a Tunisian hospital and characterization of their integrons and

GW 572016 virulence factors. J Chemother 2010, 22:318–323.PubMed 26. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G: The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008, 61:1024–1028.PubMedCrossRef 27. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E: Virulence of Escherichia coli clinical

isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012, 80:1554–1562.PubMedCrossRef 28. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O’Callaghan D, Nicolas-Chanoine MH: Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 2012, 7:e34294.PubMedCrossRef 29. Pullinger GD, Lax AJ: A Salmonella dublin virulence plasmid locus that affects bacterial growth under nutrient-limited conditions. Mol Microbiol 1992, 6:1631–1643.PubMedCrossRef 30. Shin J, Kim DH, Ko KS: Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. J Infect 2011, 63:39–47.PubMedCrossRef 31. Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JD: Alanine-glyoxylate transaminase 5-Fluoracil cost The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 2011, 71:106–109.PubMedCrossRef 32. Peirano G, Moolman J, Pitondo-Silva A, Pitout JD: The characteristics of VIM-1-producing Klebsiella pneumoniae from South Africa. Scand J Infect Dis 2012, 44:74–78.PubMedCrossRef 33. Williams JJ, Hergenrother PJ: Artificial activation of toxin–antitoxin systems as an antibacterial strategy.

Trends Microbiol 2012, 20:291–298.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions Conception and design of the study: BM, GA, AH. Laboratory work: BM, HH, NG. Data analysis and interpretation: BM, JJ. Manuscript writing, review, and/or revision: BM, GA, AH. All authors read and approved the final manuscript.”
“Background Microbial life thrives in natural waters, including those found deep in the terrestrial subsurface [1]. Groundwater there may contain little or no dissolved oxygen, and in such cases microbial activity is dominated by populations that can respire using other electron acceptors such as ferric iron, sulfate, or carbon dioxide. By catalyzing a diverse array of oxidation and reduction reactions, microorganisms (i.e.

Comments are closed.